118 related articles for article (PubMed ID: 9000665)
1. Donor origin of a posttransplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping.
Donovan JA; Simmons FA; Esrason KT; Jamehdor M; Busuttil RW; Novak JM; Grody WW
Transplantation; 1997 Jan; 63(1):80-4. PubMed ID: 9000665
[TBL] [Abstract][Full Text] [Related]
2. In situ hybridization for the Y chromosome reveals a donor origin for a posttransplant lymphoproliferative disorder in a sex-mismatched hepatic allograft.
Hegele RG; Bicknell SG; Bailey DJ; Cameron RG
Arch Pathol Lab Med; 1994 Aug; 118(8):795-6. PubMed ID: 8060227
[TBL] [Abstract][Full Text] [Related]
3. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Weiss LM; Shintaku IP; Said JW
Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905
[TBL] [Abstract][Full Text] [Related]
4. Donor transmission of malignant melanoma to a liver graft recipient: case report and literature review.
Kim JK; Carmody IC; Cohen AJ; Loss GE
Clin Transplant; 2009; 23(4):571-4. PubMed ID: 19681978
[TBL] [Abstract][Full Text] [Related]
5. Donor-transmitted malignancy in a liver transplant recipient: a case report and review of literature.
Kim B; Woreta T; Chen PH; Limketkai B; Singer A; Dagher N; Cameron A; Lin MT; Kamel I; Gurakar A
Dig Dis Sci; 2013 May; 58(5):1185-90. PubMed ID: 23242807
[TBL] [Abstract][Full Text] [Related]
6. Donor origin of neuroendocrine carcinoma in 2 transplant patients determined by molecular cytogenetics.
Baehner R; Magrane G; Balassanian R; Chang C; Millward C; Wakil AE; Osorio RW; Waldman FM
Hum Pathol; 2000 Nov; 31(11):1425-9. PubMed ID: 11112220
[TBL] [Abstract][Full Text] [Related]
7. The Onset of de novo Hepatocellular Carcinoma after Liver Transplantation can be both of Donor and Recipient origin. A Case Report.
Tamè M; Calvanese C; Cucchetti A; Gruppioni E; Colecchia A; Bazzoli F
J Gastrointestin Liver Dis; 2015 Sep; 24(3):387-9. PubMed ID: 26405713
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation.
Hruban RH; Long PP; Perlman EJ; Hutchins GM; Baumgartner WA; Baughman KL; Griffin CA
Am J Pathol; 1993 Apr; 142(4):975-80. PubMed ID: 7682765
[TBL] [Abstract][Full Text] [Related]
9. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
[TBL] [Abstract][Full Text] [Related]
10. Death from donor-transmitted malignancy despite emergency liver retransplantation.
Lipshutz GS; Baxter-Lowe LA; Nguyen T; Jones KD; Ascher NL; Feng S
Liver Transpl; 2003 Oct; 9(10):1102-7. PubMed ID: 14526407
[TBL] [Abstract][Full Text] [Related]
11. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection.
Grimm PC; Nickerson P; Jeffery J; Savani RC; Gough J; McKenna RM; Stern E; Rush DN
N Engl J Med; 2001 Jul; 345(2):93-7. PubMed ID: 11450677
[TBL] [Abstract][Full Text] [Related]
12. Urothelial carcinoma of donor origin in a kidney transplant patient.
Michel Ortega RM; Wolff DJ; Schandl CA; Drabkin HA
J Immunother Cancer; 2016; 4():63. PubMed ID: 27777772
[TBL] [Abstract][Full Text] [Related]
13. Y-chromosome status identification suggests a recipient origin of posttransplant non-small cell lung carcinomas: chromogenic in situ hybridization analysis.
Chen W; Brodsky SV; Zhao W; Otterson GA; Villalona-Calero M; Satoskar AA; Hasan A; Pelletier R; Ivanov I; Ross P; Nadasdy T; Shilo K
Hum Pathol; 2014 May; 45(5):1065-70. PubMed ID: 24746212
[TBL] [Abstract][Full Text] [Related]
14. Recurrent sarcoidosis in lung transplant allografts: granulomas are of recipient origin.
Ionescu DN; Hunt JL; Lomago D; Yousem SA
Diagn Mol Pathol; 2005 Sep; 14(3):140-5. PubMed ID: 16106194
[TBL] [Abstract][Full Text] [Related]
15. Donor-derived metastatic melanoma in a liver transplant recipient established by DNA fingerprinting.
Bilal M; Eason JD; Das K; Sylvestre PB; Dean AG; Vanatta JM
Exp Clin Transplant; 2013 Oct; 11(5):458-63. PubMed ID: 23534438
[TBL] [Abstract][Full Text] [Related]
16. Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis.
Kakar S; Burgart LJ; Charlton MR; Saito Y; Halling K; Thibodeau SN
Hum Pathol; 2002 Apr; 33(4):435-6. PubMed ID: 12055679
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-associated leiomyosarcomas in liver transplantation recipients. Origin from either donor or recipient tissue.
Timmons CF; Dawson DB; Richards CS; Andrews WS; Katz JA
Cancer; 1995 Oct; 76(8):1481-9. PubMed ID: 8620427
[TBL] [Abstract][Full Text] [Related]
18. Delayed recurrence of hepatocellular carcinoma after liver transplantation: detection of origin by chromosomal analysis.
Al-Joundi T; Gibson S; Brunt EM; Shakil O; Lee RS; Di Bisceglie AM
Liver Transpl; 2000 May; 6(3):374-5. PubMed ID: 10827244
[TBL] [Abstract][Full Text] [Related]
19. Systemic chimerism in sex-mismatched liver transplant recipients detected by fluorescence in situ hybridization.
Nagler A; Ilan Y; Amiel A; Eid A; Tur-Kaspa R
Transplantation; 1994 May; 57(10):1458-61. PubMed ID: 8197608
[TBL] [Abstract][Full Text] [Related]
20. Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation.
Loh E; Couch FJ; Hendricksen C; Farid L; Kelly PF; Acker MA; Tomaszewski JE; Malkowicz SB; Weber BL
JAMA; 1997 Jan; 277(2):133-7. PubMed ID: 8990338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
